Barclays Initiates Coverage of Edwards Lifesciences at Overweight

Fintel reports that on October 7, 2026, Barclays initiated coverage of Edwards Lifesciences (NYSE:EW) (SWX:EW) with a Overweight recommendation.Edwards Lifesciences Corporation, based in the United States, operates primarily in the healthcare sector, focusing on the development a https://www.nasdaq.com/articles/barclays-initiates-coverage-edwards-lifesciences-overweight